Degrees of Dependency: Drug Companies & Patient Groups
Submitted by Bob Burton on
In a survey of 29 U.S. patient groups, New Scientist found only two ruled out drug company funding. Seven of the patient groups surveyed received less than 5% of their income from drug companies, while others were reliant on them for over one-third of their budget.

"We all knew it would come to this, didn't we?" a Las Vegas Review-Journal editorial asks, of a new offer by the